Senior Principal Scientist, Clinical Pharmacology and Pharmacometrics
Veröffentlicht:
21 September 2024Pensum:
100%Vertrag:
Festanstellung- Arbeitsort:Long
Johnson & Johnson Innovative Medicine is recruiting for a Senior Principal Scientist, Clinical Pharmacology and Pharmacometrics, located in Spring House, PA or Raritan, NJ. Remote work options within the US may be considered on a case-by-case basis.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
For more than 130 years, diversity, equity & inclusion (DEI) has been a part of our cultural fabric at Johnson & Johnson and woven into how we do business every day. Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world. Our diverse workforce and culture of belonging accelerate innovation to solve the world’s most pressing healthcare challenges.
We know that the success of our business – and our ability to deliver meaningful solutions – depends on how well we understand and meet the diverse needs of the communities we serve. Which is why we foster a culture of inclusion and belonging where all perspectives, abilities and experiences are valued and our people can reach their potential.
At Johnson & Johnson, we all belong.
The Therapeutic Area (TA) Clinical Pharmacology (CP) Senior Principal Scientist role within Clinical Pharmacology & Pharmacometrics (CPP) is to apply and promote clinical pharmacology expertise including the design of clinical pharmacology components of simple and complex clinical studies, pharmacokinetics (PK), pharmacodynamics (PD) analysis and reporting, and application of principles of model-informed drug development (MIDD) to programs in all stages of development, ranging from pre-New Molecular Entity (NME) declaration through post-marketing support. The Senior Principal Scientist CPP Leader is responsible and accountable for developing compound specific Clinical Pharmacology strategy for the development of a compound, including interactions with regulatory agencies and functions as CPP Leader on the Compound Development Teams (CDT). The Senior Principal Scientist CPP leader can independently drive the clinical pharmacology aspects of the assigned programs and may provide management directly or indirectly to junior CPP leaders.
Key Responsibilities:
- Developing and executing CP development strategy in supporting the selection of the right dose-regimen, in the right population, using the relevant biomarkers and the right endpoint to achieve differentiation and develop a CP package that enables global product registration.
- Accountable for all CP trial design, analysis of data, reporting and interpretation of results.
- Design and execution of appropriate modeling plans along with the Pharmacometric scientist assigned to the project.
- Conducting hands-on pharmacokinetic and pharmacokinetic-pharmacodynamic analysis for drug development projects.
- Contribute to the required components of regulatory submissions and be responsible for responding to regulatory authority queries.
- Provide mentorship to CP colleagues on hands-on aspects of clinical pharmacology.
- Drive early alignment on key development questions where CP principles could be applied.
- Attend governance meetings, as necessary, ensure that CP plans are flawlessly executed, on time for efficient decision making.
- Lead the integration of input from all relevant functions as well as the preferred sourcing partners to formulate an efficient execution plan.
- Ensure access to optimum capabilities including resourcing for CP studies, developing sustainable strategy to acquire or develop internally all necessary CP techniques that are aligned with the disease area of interest to Janssen R&D.
- Acquire or develop internally, tools and training to enable identification and development of question-based drug development opportunities.